Aude Boclé
General Manager
View from the Top

Generating Partnerships to Boost Nutrition and Probiotics

Thu, 12/20/2018 - 10:20

Q: How does Biocodex’s offering differ in Mexico and how has that helped you build your presence in the country?
A: Until 2018, Biocodex mainly marketed one pharmaceutical product called Floratil, which has been in the market for 25 years. This has given us the credibility of a growing company that delivers on the promises of its products. The scientific research behind Floratil makes it a unique probiotic in the market regarding effects and benefits, ensuring safety and quality. Biocodex will complement its microbiota offer with a new offer of probiotics food supplement. Besides its portfolio of microbiota brands, Biocodex is proposing a unique platform of communication through its Biocodex Microbiota Institute to inform and educate both patients and healthcare professionals on microbiota.
Q: What is the company’s strategy to develop its business inorganically?
A: Biocodex recently signed an alliance with Nutricia, Danone's specialized nutrition branch, to distribute and promote its infant formula range. This line of nutritional products and baby formulas benefit of over 120 years of research in nutrition and 40 years of research in breast milk. Our goal with this partnership is to evolve from a mono-product status to a more visible and larger operation that represents a very good business opportunity, since we are entering a market that is now ten times larger than the probiotic one.
At Biocodex we are convinced that nutrition during the first thousand days of life is a key factor for growth, development and the microbiota. That is why we are now interested in offering options that fulfill the nutritional needs of all children. In this purpose, Nutricia portfolio perfectly fits the microbiota focus of Biocodex. Nutricia and Biocodex both have a similar long-term vision for the development of their operations and footprint in Mexico.
Q: How do you tropicalize your strategies to the needs of the local market?
A: Biocodex has a global strategy that integrates local constraints, priorities, strategies and environmental conditions. The decisions we make at our headquarters are locally implemented, taking all those aspects into consideration. We are aware of the challenges that Mexico faces in terms of chronic and serious diseases and, considering our microbiota focus, the best way we can tackle these issues is through prevention and education. Nutricia's specialized nutrition line suits this objective as an adapted nutrition in early age can positively impact a patient's life.
Floratil not only allows to treat gastrointestinal issues but also has preventive actions. In the second half of 2019, we will also launch a new probiotic-based food supplement line focused on well-being and prevention. Among those products, CYSTALIA will focus on prevention of cystitis in women and DIFESIA will strengthen the immune system to prevent infections. We will launch this line globally, which is a key moment for Biocodex because it will fuel our mission to develop our leadership in the microbiota area. The products will be distributed worldwide and the only difference might be the name of the products given regulatory constraints.
Q: How would you rank research in Mexico regarding microbiota?
A: For a couple of years, microbiota has become one of the fastest growing areas of medical research worldwide. The scientific community recently discovered that microbiota could be considered another organ of the human body as it can influence physiological functions outside the gastrointestinal system such as neurological, metabolic or immune functions. We have realized R&D is highly active in Mexico and that microbiota is also an area of particular interest among researchers. Biocodex Microbiota Foundation’s goal is to promote research in microbiota around the world. To achieve this objective, Biocodex Group has been providing grants to researchers in all countries where it directly operates. In September 2018, we celebrated the first grant in Mexico offered to a team of scientists in Michoacan.